The U.S. Food and Drug Administration (FDA) has announced the most serious type of market recall (Class I) for Impella heart pump controllers manufactured by a company owned by Johnson & Johnson, citing discovered cybersecurity flaws.
The U.S. Senate has passed an amendment to the defense budget bill banning federal funding for projects involving Chinese biotechnology companies deemed a threat to national security.
OpenAI and Broadcom have entered into a partnership that will result in the first dedicated AI chips in OpenAI’s history. The company aims to reduce its reliance on external chip manufacturers — and the market response has been overwhelmingly positive.
The European Commission has unveiled a new program, Apply AI, which includes €1 billion in funding to accelerate the adoption of artificial intelligence across strategic sectors of the economy.